PubMed · 1997 · 44 citations · 23 references
Life SciencesCell BiologyMolecular BiologyCell SignalingLactationSignal TransductionGrowth Factor SignalingMammary Epithelial Cell BiologyMammary Gland DevelopmentMilk ProteinsMilk SecretionMilk SynthesisEpidermal Growth Factor Receptor SignalingMammary Epithelial Gene RegulationMilk Protein Gene ExpressionPhosphatidylinositol 3-Kinase PathwayPhosphatidylinositol 3-Kinase-akt PathwayPhosphatidylinositol 3-Kinase-akt SignalingTyrosine Kinase InhibitionTyrosine Kinase Receptors
Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein beta-casein. In contrast, simultaneous treatment of mouse HC-11 cells with CR-1 in the presence of DIP inhibited beta-casein expression. The inhibitory effects of CR-1 on beta-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because beta-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on beta-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21ras farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of beta-casein is mediated through a p21ras-dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC-11 cells.
23
Roland K. Ball, Robert R. Friis, Cora‐Ann Schoenenberger et al. · The EMBO Journal · 1988 · 514 citations · Full text
Gertraud W. Robinson, Robert A. McKnight, Gilbert H. Smith et al. · Development · 1995 · 300 citations
Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
Ana M. García, Cheryl A. Rowell, Karen Ackermann et al. · Journal of Biological Chemistry · 1993 · 222 citations · Full text
Medicine, Oncology, Pharmacology +15